While the Pennsylvania site is shutting down, the layoffs are not limited to that location. According to a WARN notice filed ...

At the annual meeting of the European Society of Cardiology, being held this weekend in Madrid, new cardiac care guidelines call for a more uniform, simplified and accessible approach to | The latest ...

The National Cancer Institute (NCI) is ending its support for a 26-year-old push to advance clinical trials for children with ...

A new foundation from the estate of late Microsoft co-founder Paul Allen has launched with a set of four research grant ...

Wugen has raised $115 million, tapping a Fidelity-led syndicate to fund its pursuit of FDA approval for the first ...

Zydus Therapeutics has racked up a phase 2b/3 win in primary biliary cholangitis (PBC), clearing the path to a filing to establish the company as a challenger to Gilead, Intercept Pharmaceuticals and ...

Plexium has raised $60.1 million, providing an infusion of cash for the r | Plexium has raised $60.1 million, providing an infusion of cash to the recently slimmed-down protein degrader specialist ...

Novartis is putting down $30 million, with a potential $772 million on the line, to work with BioArctic’s tech to find a new ...

Oral therapy Relyvrio, which Amylyx is again referring to as AMX0035, was tested in progressive supranuclear palsy (PSP), a ...

Eight months after Sanofi’s former chief medical officer, Dietmar Berger, M.D., departed, the French drugmaker has selected ...

At AbbVie, bretisilocin will slot into a well-established neuroscience unit. AbbVie has deals with Gedeon Richter, the source ...

Abbott has collected a green light in Europe for its dissolving, drug-laden stent in peripheral artery disease, following its ...